Warner Chilcott Sues Lupin Over Femcon, Loestrin IP

Law360, New York (September 14, 2009, 6:14 PM EDT) -- Ireland-based Warner Chilcott PLC’s U.S. unit has filed two lawsuits accusing generic-drug maker Lupin Ltd. of violating patents for birth control drugs Loestrin 24 Fe and Femcon Fe.

Warner Chilcott Co. LLC filed the suits Thursday in the U.S. District Court for the District of Maryland, one alleging infringement of the patent for Loestrin and the other for infringement of a Femcon patent.

India-based Lupin and its U.S. unit, Lupin Pharmaceuticals Inc., filed abbreviated new drug applications with the U.S. Food and Drug Administration to make...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.